Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Kirin Cashes Out of Amgen Drug Joint Venture for $780M October 30, 2017 Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III December 21, 2017 TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018
TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018
